Expression of concern
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
Paper Information
Record ID:
35467
Author(s):
Heather Wilson
George Dervenoulas
Gennaro Pagano
Christos Koros
Tayyabah Yousaf
Marina Picillo
Sotirios Polychronis
Athina Simitsi
Beniamino Giordano
Zachary Chappell
Benjamin Corcoran
Maria Stamelou
Roger N Gunn
Maria Teresa Pellecchia
Eugenii A Rabiner
Paolo Barone
Leonidas Stefanis
Marios Politis
George Dervenoulas
Gennaro Pagano
Christos Koros
Tayyabah Yousaf
Marina Picillo
Sotirios Polychronis
Athina Simitsi
Beniamino Giordano
Zachary Chappell
Benjamin Corcoran
Maria Stamelou
Roger N Gunn
Maria Teresa Pellecchia
Eugenii A Rabiner
Paolo Barone
Leonidas Stefanis
Marios Politis
Journal:
Publication Date:
June 19, 2019
Retraction Date:
January 18, 2022
(3.8 years years ago)
Subjects:
Institutions:
- Neurodegeneration Imaging Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- University of Athens Medical School, 1st Department of Neurology, University of Athens Hospital Attikon, Greece
- Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Neuroscience Section, University of Salerno, Italy
- Nuclear Medicine Department, King's College Hospital NHS Foundation Trust, London, UK
- Department of Neurology, Philipps University, Marburg, Germany
- Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece
- Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK
- Invicro LLC, Centre for Imaging Sciences, Hammersmith Hospital, London, UK
- Center of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece
Countries:
Article Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1016/S1474-4422(22)00030-8Citations (87)
87
Total Citations45
Post-Retraction(51.7%)
41
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
16
Within 1 year
19
After 2+ years
1267
Days since retraction (latest)
Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs
Audrey Maillet, Élise Météreau, Léon Tremblay et al. (13 authors)
Movement Disorders
Published: Sep 2021
59 citations
59 citations
132 days before retraction
Multiplexed analysis of amino acids in mice brain microdialysis samples using isobaric labeling and liquid chromatography-high resolution tandem mass spectrometry
Juho Heininen, Ulrika Julku, Timo T. Myöhänen et al. (5 authors)
Journal of Chromatography A
Open Access
Published: Sep 2021
9 citations
9 citations
133 days before retraction
Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease
Trina Mitchell, Stéphane Lehericy, Shannon Chiu et al. (6 authors)
JAMA Neurology
Open Access
Published: Aug 2021
157 citations
157 citations
141 days before retraction
Highlighting Immune System and Stress in Major Depressive Disorder, Parkinson’s, and Alzheimer’s Diseases, with a Connection with Serotonin
Ana Salomé Correia, Armando Cardoso, Nuno Vale
International Journal of Molecular Sciences
Open Access
Published: Aug 2021
33 citations
33 citations
164 days before retraction
Increasing Serotonin to Reduce Parkinsonian Tremor
Daniele Caligiore, Francesco Montedori, Silvia Buscaglione et al. (4 authors)
Frontiers in Systems Neuroscience
Open Access
Published: Jul 2021
9 citations
9 citations
182 days before retraction
Nervonic Acid Ameliorates Motor Disorder in Mice with Parkinson’s Disease
Dandong Hu, Yujuan Cui, Ji Zhang
Neurochemical Journal
Published: Jul 2021
7 citations
7 citations
201 days before retraction
Genotype-driven therapeutic developments in Parkinson’s disease
Jannik Prasuhn, Norbert Brüggemann
Molecular Medicine
Open Access
Published: Apr 2021
33 citations
33 citations
274 days before retraction
A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson’s disease (PASADENA): rationale, design and baseline data
Gennaro Pagano, Frank Boess, Kirsten I. Taylor et al. (26 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2021
8 citations
8 citations
278 days before retraction
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice
Rubén Pavia-Collado, Valentín Cóppola-Segovia, Lluís Miquel-Rio et al. (13 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2021
16 citations
16 citations
311 days before retraction
Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease
Yanyan Zhang, Jie Li, Xiao Zhang et al. (5 authors)
Frontiers in Neuroscience
Open Access
Published: Feb 2021
11 citations
11 citations
349 days before retraction
Parkinson patients have a presynaptic serotonergic deficit: A dynamic deep brain stimulation PET study
Louise Møller Jørgensen, Tove Henriksen, Skirmante Mardosiene et al. (11 authors)
Journal of Cerebral Blood Flow & Metabolism
Open Access
Published: Jan 2021
23 citations
23 citations
365 days before retraction
Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism
David J. Brooks
Neurotherapeutics
Open Access
Published: Jan 2021
5 citations
5 citations
371 days before retraction
Serotonergic control of the glutamatergic neurons of the subthalamic nucleus
Luisa Ugedo, Philippe De Deurwaerdère
Progress in brain research
Published: Jan 2021
4 citations
4 citations
382 days before retraction
Serotonergic imaging in Parkinson's disease
Edoardo Rosario de Natale, Heather Wilson, Marios Politis
Progress in brain research
Published: Jan 2021
18 citations
18 citations
382 days before retraction
Nervonic acid amends motor disorder in a mouse model of Parkinson’s disease
Dandong Hu, Yujuan Cui, Ji Zhang
Translational Neuroscience
Open Access
Published: Jan 2021
17 citations
17 citations
382 days before retraction
The alphasynucleinopathies: Parkinson’s disease, Lewy body dementia, and multisystem atrophy
Helmut Hildebrandt
Elsevier eBooks
Published: Dec 2020
398 days before retraction
A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
Anna Castrioto, Stéphane Thobois, Mathieu Anheim et al. (19 authors)
npj Parkinson s Disease
Open Access
Published: Dec 2020
23 citations
23 citations
399 days before retraction
Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
Heather Wilson, Marios Politis, Eugenii A. Rabiner et al. (4 authors)
Cells
Open Access
Published: Dec 2020
28 citations
28 citations
412 days before retraction
REM sleep behavior disorder and other sleep abnormalities in p. A53T SNCA mutation carriers
Athina Maria Simitsi, Christos Koros, María Stamelou et al. (12 authors)
SLEEP
Open Access
Published: Nov 2020
16 citations
16 citations
420 days before retraction
Intracellular A53T Mutant α-Synuclein Impairs Adult Hippocampal Newborn Neuron Integration
Martin Regensburger, Judith Stemick, Eliezer Masliah et al. (5 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Nov 2020
6 citations
6 citations
433 days before retraction
Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor Complications
Jared T. Hinkle, Kate Perepezko, Lorenzo Gonzalez et al. (5 authors)
Movement Disorders Clinical Practice
Open Access
Published: Nov 2020
14 citations
14 citations
440 days before retraction
On the heterogeneity of depression in Parkinson’s disease
M. R. Nodel, N. N. Yakhno
Neurology neuropsychiatry Psychosomatics
Open Access
Published: Oct 2020
2 citations
2 citations
450 days before retraction
Sub-second Dopamine and Serotonin Signaling in Human Striatum during Perceptual Decision-Making
Dan Bang, Kenneth T. Kishida, Terry Lohrenz et al. (8 authors)
Neuron
Open Access
Published: Oct 2020
109 citations
109 citations
463 days before retraction
Parkinson’s Disease
Michele Matarazzo, André C. Felício, A. Jon Stoessl
Springer eBooks
Published: Oct 2020
1 citation
1 citation
464 days before retraction
Functions of p38 MAP Kinases in the Central Nervous System
Prita R. Asih, Emmanuel Prikas, Kristie Stefanoska et al. (6 authors)
Frontiers in Molecular Neuroscience
Open Access
Published: Sep 2020
122 citations
122 citations
497 days before retraction
Breathing new life into neurotoxic-based monkey models of Parkinson's disease to study the complex biological interplay between serotonin and dopamine
Véronique Sgambato‐Faure
Progress in brain research
Published: Aug 2020
4 citations
4 citations
518 days before retraction
Imaging of dopamine transporters in Parkinson disease: a meta‐analysis of <sup>18</sup>F/<sup>123</sup>I‐FP‐CIT studies
Yanyan Kong, Chencheng Zhang, Kawai Liu et al. (6 authors)
Annals of Clinical and Translational Neurology
Open Access
Published: Aug 2020
9 citations
9 citations
522 days before retraction
All roads lead to the motor cortex: psychomotor mechanisms and their biochemical modulation in psychiatric disorders
Georg Northoff, Dušan Hirjak, Robert Christian Wolf et al. (5 authors)
Molecular Psychiatry
Published: Jun 2020
164 citations
164 citations
580 days before retraction
Whole-exome analysis in Parkinson’s disease reveals a high burden of ultra rare variants in early onset cases
Bernabé I. Bustos, Dimitri Krainc, Steven Lubbe
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2020
4 citations
4 citations
591 days before retraction
Long-Term Treatment with Fluvoxamine Decreases Nonmotor Symptoms and Dopamine Depletion in a Postnatal Stress Rat Model of Parkinson’s Disease
Ernest Dallé, Willie M. U. Daniels, Musa V. Mabandla
Oxidative Medicine and Cellular Longevity
Open Access
Published: Mar 2020
20 citations
20 citations
668 days before retraction
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
Patrik Fazio, Daniel Ferreira, Per Svenningsson et al. (7 authors)
European Journal of Nuclear Medicine and Molecular Imaging
Open Access
Published: Feb 2020
17 citations
17 citations
714 days before retraction
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
David Matuskey, Sule Tinaz, Kyle C. Wilcox et al. (15 authors)
Annals of Neurology
Open Access
Published: Jan 2020
158 citations
158 citations
731 days before retraction
The Pharmacology of Visual Hallucinations in Synucleinopathies
Mirella Russo, Claudia Carrarini, Fedele Dono et al. (10 authors)
Frontiers in Pharmacology
Open Access
Published: Dec 2019
48 citations
48 citations
771 days before retraction
Human Periapical Cyst-Derived Stem Cells Can Be A Smart “Lab-on-A-Cell” to Investigate Neurodegenerative Diseases and the Related Alteration of the Exosomes’ Content
Marco Tatullo, Bruna Codispoti, Gianrico Spagnuolo et al. (4 authors)
Brain Sciences
Open Access
Published: Dec 2019
15 citations
15 citations
775 days before retraction
Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease
Lorena Jiménez‐Sánchez, Javier Blesa, Natalia López‐González del Rey et al. (6 authors)
Neuropharmacology
Open Access
Published: Oct 2019
16 citations
16 citations
837 days before retraction
Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease
Eliseu da Cruz Moreira-Junior
Medical Hypotheses
Published: Sep 2019
3 citations
3 citations
857 days before retraction
Serotonergic pathology and Braak's staging hypothesis in Parkinson's disease
Katharina A. Schindlbeck, David Eidelberg
The Lancet Neurology
Published: Jun 2019
9 citations
9 citations
944 days before retraction
Quick Stats
Total Citations:
87
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025